Doris May
Payments from drug & device makers
Across 111 payments — averaging $34.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$639
- Otsuka America Pharmaceutical, Inc.$522
- Vanda Pharmaceuticals Inc.$485
- Corium, LLC$448
- Johnson & Johnson$303
- Axsome Therapeutics, Inc.$261
- plus $1K from 12 others
What the payments were for
- Food & beverage$3,836100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $639 |
| Otsuka America Pharmaceutical, Inc. | 10 | $522 |
| Vanda Pharmaceuticals Inc. | 13 | $485 |
| Corium, LLC | 21 | $448 |
| Johnson & Johnson | 7 | $303 |
| Axsome Therapeutics, Inc. | 7 | $261 |
| Jazz Pharmaceuticals Inc. | 2 | $226 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $175 |
| Teva Pharmaceuticals USA, Inc. | 4 | $164 |
| Lundbeck LLC | 7 | $134 |
| Collegium Pharmaceutical, Inc. | 1 | $106 |
| Supernus Pharmaceuticals, Inc. | 6 | $99 |
| Ironshore Pharmaceuticals Inc. | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $64 |
| Neurocrine Biosciences, Inc. | 3 | $54 |
| Noven Therapeutics, LLC | 2 | $40 |
| OWP Pharmaceuticals, Inc. | 1 | $22 |
| Adlon Therapeutics L.p. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few school providers in Indianato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 44 | $556 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 12 | $298 |
| Quetiapine Fumarate | 20 | $206 |
| Escitalopram Oxalate | 31 | $181 |
| Alprazolam | 43 | $163 |
| Sertraline Hcl | 21 | $137 |
| Lorazepam | 11 | $99 |
| Clonazepam | 23 | $94 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.